C. T. de Lara

发表

Variables with time-varying effects and the Cox model: Some statistical concepts illustrated with a prognostic factor study in breast cancer

Gaëtan MacGrogan, Simone Mathoulin-Pélissier, Carine A Bellera, 2010, BMC medical research methodology.

Epithelial atypia: a marker risk of concomitant or subsequent breast carcinoma?

A. Vincent-Salomon, V. Brouste, I. de Mascarel, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations.

M. Dilhuydy, B. Barreau, I. de Mascarel, 2005, European journal of radiology.

Time for reappraisal of progesterone-receptor testing in breast cancer management.

I. de Mascarel, G. MacGrogan, S. Mathoulin-Pélissier, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trials

G. MacGrogan, S. Mathoulin-Pélissier, J. Lemonnier, 2020, British Journal of Cancer.

Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial.

C. T. de Lara, J. Rodier, M. Velten, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.

H. Bartelink, I. Fentiman, S. Litière, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas.

V. Brouste, G. MacGrogan, N. Sevenet, 2022, Cancer genetics.

Outcome and prognostic factors in breast sarcoma: a multicenter study from the rare cancer network.

N. Magné, M. Bolla, M. Ozsahin, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis

V. Brouste, I. de Mascarel, G. MacGrogan, 2012, BMC Medical Genomics.

Neoadjuvant endocrine treatment in breast cancer: analysis of daily practice in large cancer center to facilitate decision making.

V. Brouste, G. MacGrogan, L. Mauriac, 2014, American journal of surgery.

Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer

M. Nikolski, G. MacGrogan, H. Bonnefoi, 2015, British Journal of Cancer.

Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study

R. Rouzier, C. Lefebvre, P. Gimbergues, 2018, Breast Cancer Research and Treatment.

Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases.

F. Penault-Llorca, P. Maingon, P. Romestaing, 2010, Critical reviews in oncology/hematology.

A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 cases.

B. Bui, J. Coindre, C. T. de Lara, 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[Primary breast sarcoma. A retrospective study of 42 patients treated at the Bergonié Institute during a 32-year period].

B. Bui, J. Coindre, G. MacGrogan, 2004, Journal de gynecologie, obstetrique et biologie de la reproduction.

Application of the Van Nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examinated by serial macroscopic sectioning: Practical considerations

J. Coindre, I. de Mascarel, G. MacGrogan, 2000, Breast Cancer Research and Treatment.

Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit

E. Darai, R. Rouzier, P. Colombo, 2019, Breast Cancer Research and Treatment.

Ductal Carcinoma in Situ: A French National Survey. Analysis of 2125 Patients.

C. T. de Lara, C. Lemanski, C. Cuvier, 2019, Clinical breast cancer.

Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort☆

R. Rouzier, F. Reyal, C. Coutant, 2021, ESMO open.

Exclusive intraoperative radiotherapy for invasive breast cancer in elderly patients (>70 years): proportion of eligible patients and local recurrence-free survival

P. Gimbergues, D. Hudry, C. T. de Lara, 2016, BMC Surgery.

Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial: axillary dissection versus no axillary dissection in patients with involved sentinel node

E. Darai, A. Agostini, P. Colombo, 2018, BMC Cancer.

[Breast biopsies: stereotactic vacuum-assisted core biopsy and stereotactic surgical breast biopsy].

M. Dilhuydy, B. Barreau, C. T. de Lara, 2003, Gynecologie, obstetrique & fertilite.

Prospective Multicenter Study Validate a Prediction Model for Surgery Uptake Among Women with Atypical Breast Lesions

M. Espié, S. Michiels, C. Coutant, 2020, Annals of Surgical Oncology.